Ratings
0
Nobody has rated this yet. Be the first!
Works
10
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
RAD51C is a susceptibility gene for ovarian cancer
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
